Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter F Weller

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Frontiers in Cell and Developmental Biology|April 7, 2022
Mitochondrial Population in Mouse Eosinophils: Ultrastructural Dynamics in Cell Differentiation and Inflammatory DiseasesKennedy Bonjour, Cinthia Palazzi, Thiago P Silva, et al.
Mayo Clinic Proceedings|September 20, 2021
Eosinophils in Health and Disease: A State-of-the-Art ReviewMichael E Wechsler, Ariel Munitz, Steven J Ackerman, et al.
International Immunopharmacology|November 9, 2005
Anti-allergic properties of the bromeliaceae Nidularium procerum: inhibition of eosinophil activation and influxAdriana Vieira-de-Abreu, Fábio C Amendoeira, Gleice S Gomes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2017
Measuring Success in Global Health Training: Data From 14 Years of a Postdoctoral Fellowship in Infectious Diseases and Tropical MedicineJoseph D Tucker, Molly A Hughes, Ravi V Durvasula, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitisJonathan Steinfeld, Eric S Bradford, Judith Brown, et al.
Plos One|October 9, 2015
Purinergic P2Y12 Receptor Activation in Eosinophils and the Schistosomal Host ResponseValdirene S Muniz, Renata Baptista-Dos-Reis, Claudia F Benjamim, et al.
The New England Journal of Medicine|March 18, 2008
Treatment of patients with the hypereosinophilic syndrome with mepolizumabMarc E Rothenberg, Amy D Klion, Florence E Roufosse, et al.
The New England Journal of Medicine|May 18, 2017
Mepolizumab or Placebo for Eosinophilic Granulomatosis with PolyangiitisMichael E Wechsler, Praveen Akuthota, David Jayne, et al.
The Journal of Allergy and Clinical Immunology|March 31, 2012
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromesPeter Valent, Amy D Klion, Hans-Peter Horny, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2012
Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD)Bruce S Bochner, Wendy Book, William W Busse, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Frontiers in Cell and Developmental Biology|April 7, 2022
Mitochondrial Population in Mouse Eosinophils: Ultrastructural Dynamics in Cell Differentiation and Inflammatory DiseasesKennedy Bonjour, Cinthia Palazzi, Thiago P Silva, et al.
Mayo Clinic Proceedings|September 20, 2021
Eosinophils in Health and Disease: A State-of-the-Art ReviewMichael E Wechsler, Ariel Munitz, Steven J Ackerman, et al.
International Immunopharmacology|November 9, 2005
Anti-allergic properties of the bromeliaceae Nidularium procerum: inhibition of eosinophil activation and influxAdriana Vieira-de-Abreu, Fábio C Amendoeira, Gleice S Gomes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2017
Measuring Success in Global Health Training: Data From 14 Years of a Postdoctoral Fellowship in Infectious Diseases and Tropical MedicineJoseph D Tucker, Molly A Hughes, Ravi V Durvasula, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitisJonathan Steinfeld, Eric S Bradford, Judith Brown, et al.
Plos One|October 9, 2015
Purinergic P2Y12 Receptor Activation in Eosinophils and the Schistosomal Host ResponseValdirene S Muniz, Renata Baptista-Dos-Reis, Claudia F Benjamim, et al.
The New England Journal of Medicine|March 18, 2008
Treatment of patients with the hypereosinophilic syndrome with mepolizumabMarc E Rothenberg, Amy D Klion, Florence E Roufosse, et al.
The New England Journal of Medicine|May 18, 2017
Mepolizumab or Placebo for Eosinophilic Granulomatosis with PolyangiitisMichael E Wechsler, Praveen Akuthota, David Jayne, et al.
The Journal of Allergy and Clinical Immunology|March 31, 2012
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromesPeter Valent, Amy D Klion, Hans-Peter Horny, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2012
Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD)Bruce S Bochner, Wendy Book, William W Busse, et al.
Pageof 13